Indication
Respiratory Insufficiency
8 clinical trials
14 products
Clinical trial
A Three-arm Randomized Controlled Non-inferiority Pilot Study Comparing Anticoagulation Strategies Using Unfractionated Heparin, Argatroban and Low-molecular-weight Heparin for Extracorporeal Membrane Oxygenation SupportStatus: Recruiting, Estimated PCD: 2026-07-30
Product
EnoxaparinProduct
ArgatrobanProduct
Unfractionated heparinClinical trial
Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults: a Vanguard Pragmatic Randomized Controlled Trial (inDEX Trial)Status: Active (not recruiting), Estimated PCD: 2024-03-30
Product
DexmedetomidineClinical trial
Effectiveness and Safety of Telmisartan in Acute Respiratory Failure Due to COVID-19Status: Completed, Estimated PCD: 2021-05-15
Product
TelmisartanClinical trial
Impact of Totally Transdermal Sedation in the Weaning From Remifentanil Infusion Among Critically Ill Patients Undergoing Mechanical Ventilation: a Pilot Randomized-controlled Study (The TOES Trial)Status: Completed, Estimated PCD: 2024-04-06
Product
FentanylProduct
RemifentanilClinical trial
Doxapram Versus Placebo in Preterm Newborns: An International Double Blinded Multicenter Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2026-05-01
Product
DoxapramProduct
PlaceboClinical trial
Platform of Randomized Adaptive Clinical Trials in Critical IllnessStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Early Cohort corticosteroidClinical trial
Partial Neuromuscular Blockade in Acute Respiratory Distress SyndromeStatus: Terminated, Estimated PCD: 2023-03-01
Product
Neuromuscular blockadeClinical trial
Sedation Practice in Intensive Care Evaluation (SPICE IV) Early Sedation With Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients: A Prospective, Multi-Centre, Double-Blind, Randomized, Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31